Companies are now seeking to translate and expand upon the lessons they learned running DCTs during the pandemic – namely, applying DCT solutions globally.
TORONTO (PRWEB) March 01, 2021
More sponsors are seeking to launch and execute decentralized clinical trials (DCTs) than ever before. Industry watchers expect the market for DCTs to reach $10 billion by 2026, growing by 6.5% compound annual growth rate (CAGR) over the next five years. In 2020, COVID-19 catalyzed the already growing rate of DCT studies as many active studies without decentralized approaches were transitioned to support patient safety and trial continuity.
The result is that sponsors and CROs that were once slow to embrace the potential of DCTs, are now acutely aware of their advantages, such as higher patient engagement, optimized study enrollment and patient retention. With all of this in mind, companies are now seeking to translate and expand upon the lessons they learned running DCTs during the pandemic – namely, applying DCT solutions globally.
Join Trinette Mitchell, Head, Clinical Trial Innovation, Takeda and John Reites, President, THREAD in a live webinar on Tuesday, March 16, 2021 at 1pm EST to hear about best practices and lessons learned over the past years in conducting global DCTs, including how to navigate complex regulatory landscapes.
For more information, or to register for this event, visit Best Practices to Scale Global Hybrid Decentralized Studies.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.